MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Hygroscopic. Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Lymecycline 408mg capsules (Teva UK Ltd) and Tetralysal 300 capsules (Galderma (UK) Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Elvanse 30mg capsules (Takeda UK Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Elvanse 40mg capsules (Takeda UK Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Elvanse 50mg capsules (Takeda UK Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Elvanse 70mg capsules (Takeda UK Ltd).

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 375mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.